Webinar — Tariff Tensions: How Pharma Can Prepare You For Supply Chain & Cost Disruption

In the face of proposed US tariffs on foreign pharmaceutical products — including APIs, excipients, drug substances, and drug products — critical decisions loom: Should companies maintain current supply chains, build inventory, acquire domestic manufacturing, partner with a CMO, expand US operations, or seek preferred nation alternatives? And how can leaders balance business goals with patient access if passing costs to patients proves unsustainable?

For this webinar, we partnered with Pharma Ignite to examine the latest tariff status and timelines, presents data-driven analysis of strategic options, and outlines practical steps to align decisions with implementation deadlines, helping you validate your strategy or create a robust tariff contingency plan.

Interested in finding out more about how to deal with tariffs?

Talk to an Expert Learn More

Meet our Speakers

Bob Beall

Vice President, Quality and Compliance

View Bio
Ranasha Rönnkvist

Associate Director, Product Life Cycle Management

View Bio
Bram Lardee

Senior Director, Product LifeCycle Management

View Bio

Bob Beall

Robert has supported the development and commercialization of multiple cell therapy products and processes including decentralization of CD19+ CAR T therapies, development of hospital cellular therapy labs, including expansion of the NIH Center for Cellular Engineering, as well as the expansion of the first commercialized CAR-T therapy process capabilities. Other Cell therapy programs included remediation support for cellular and media manufacturing programs, and guidance for multiple CAR-T manufacturing automation advancements. Robert supported the COVID-19 response by establishing global safety systems for three major vaccines. He has led hundreds of international product transfers utilizing both internal transfers and CMO’s at multiple top 10 Pharmaceutical companies. He is a graduate of the Rochester Institute of Technology (RIT) with a BS in Engineering and has completed advanced degree studies as well as completing his PMP certification. He is an international speaker and author.

Ranasha Rönnkvist

I am a multi-industry-oriented Supply Chain professional with over 25 years of experience. I have a background in Business Management and have extensive experience as a Supply Chain Specialist working in various industries. I have managed projects and collaborated with clients across the globe for more than 20 years and understand the value of building relationships to achieve goals. I have worked in the Aerospace and Defence, FMCG, “big” pharmaceutical, and smaller biotech/biopharmaceutical sectors.

Bram Lardee

Mr. Lardée began his career as an Analytical Chemist in the vitamins and pharmaceuticals division at Solvay-Duphar (Netherlands), eventually advancing to the role of Analytical Expert. After several years in this position, he transitioned into Pharmaceutical Technology, where he was responsible for developing a wide range of dosage forms from toxicology and clinical phases through to market approval.

Leveraging his broad hands-on experience and strong ability to translate technical knowledge into strategic project execution, Mr. Lardée was appointed Global CMC Project Lead at Solvay Pharmaceuticals (later Abbott Healthcare Products). In this role, he supported multiple clinical programs and managed the lifecycle of marketed products.

Prior to joining ProPharma, he served as R&D Director at Centrient Pharmaceuticals, where he was technically accountable for establishing the Finished Dosage Forms franchise. Mr. Lardée brings over 35 years of experience in the pharmaceutical industry.